# Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

> **NCT02445612** · — · COMPLETED · sponsor: **Astellas Institute for Regenerative Medicine** · enrollment: 13 (actual)

## Conditions studied

- Stargardt's Macular Dystrophy

## Interventions

- **BIOLOGICAL:** MA09-hRPE

## Key facts

- **NCT ID:** NCT02445612
- **Lead sponsor:** Astellas Institute for Regenerative Medicine
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-11
- **Primary completion:** 2019-06-21
- **Final completion:** 2019-06-21
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02445612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02445612, "Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02445612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*